Kiora Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 12.51 million compared to USD 13.58 million a year ago. Basic loss per share from continuing operations was USD 2.69 compared to USD 18.55 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.506 USD | +4.96% | -11.99% | -2.37% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.37% | 12.66M | |
-3.16% | 102B | |
+1.66% | 96.29B | |
+2.13% | 22.18B | |
-15.86% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.71% | 16.36B | |
+5.99% | 13.97B | |
+33.97% | 12.17B |
- Stock Market
- Equities
- KPRX Stock
- News Kiora Pharmaceuticals, Inc.
- Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023